PregnancyNCT06648993
Body Awareness and Physical Activity Levels of Pregnant Women and Age, Number of Pregnancies and Gestational Week
An observational study of Pregnancy, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study was to investigate the relationship between body awareness and physical activity levels of pregnant women according to variables such as age, number of pregnancies and gestational week. Read more about this study
- Who is it for?
- Ages 18 to 49 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pregnancy
- How many people
- 140 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Sep 2024to 20 Nov 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Pregnant women
Who may be able to join
- being in the 2-3rd trimester of pregnancy and
- volunteering to participate in the study
Who cannot join
- having a risky pregnancy,
- being prohibited from physical activity by a physician,
- having any limb deficiency,
- neurological disease,
- mental deficiency
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Investigation of the Relationship Between Body Awareness and Physical Activity Levels of Pregnant Women and Age, Number of Pregnancies and Gestational Week
The aim of this study was to investigate the relationship between body awareness and physical activity levels of pregnant women according to variables such as age, number of pregnancies and gestational week. The main question it aims to answer is: do physical activity levels of pregnant women and age, number of pregnancies and gestational week have an impact on body awareness in pregnant women
- Conditions
- Pregnancy
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Awareness
The Body Awareness Questionnaire will be used to assess body awareness. The questionnaire consists of 18 questions. Participants will be asked to rate each statement on a scale ranging from 1 (1: Not true at all) to 7 (7: Completely true) and the total score will be obtained by summing the scores given for each statement. The total score takes a value between 18 and 126. The higher the total score, the better the body awareness
Measured: Baseline
Secondary outcomes (4)
Physical Activity Levels
The physical activity levels of individuals will be assessed with the International Physical Activity Questionnaire Short form (IPAQ-SF), which consists of seven questions that provide information about the number of days in the last week that the individual has engaged in high, moderate and low intensity activities, the time spent in these activities and the time spent sedentary. One criterion in this assessment is that each activity must be performed for at least 10 minutes to be included in the scoring. Minutes and days are multiplied by the metabolic equivalent of the task (MET) value and the result is expressed as MET-minutes/week. A lower value indicates a lower level of physical activity.
Measured: Baseline
Age
Participants' age will be recorded.
Measured: Baseline
Number of births
Participants' number of births will be recorded.
Measured: Baseline
weeks of gestation
Participants' weeks of gestation will be recorded.
Measured: Baselin
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Oct 2024
- Study start30 Sep 2024
- Primary completion15 Nov 2024
- Study completion20 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 140 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aslıhan Turan, KTO Karatay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06648993
- Sponsor's protocol ID
- KaratayUA2
- Status last verified
- Dec 2024
- First submitted
- 15 Oct 2024
- Last updated
- 5 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Relationship Between Body Awareness and Physical Activity Levels of Pregnant Women and Age, Number of Pregnancies and Gestational Week
- ClinicalTrials.gov ID
- NCT06648993
- Acronym / sponsor ID
- KaratayUA2
- Conditions
- Pregnancy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 140 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 30 Sep 2024 (actual)
- Primary completion
- 15 Nov 2024 (actual)
- Study completion
- 20 Nov 2024 (actual)
- First posted
- 18 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to investigate the relationship between body awareness and physical activity levels of pregnant women according to variables such as age, number of pregnancies and gestational week. The main question it aims to answer is: do physical activity levels of pregnant women and age, number of pregnancies and gestational week have an impact on body awareness in pregnant women
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 49 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Pregnant women
Key inclusion criteria (2 listed)
- being in the 2-3rd trimester of pregnancy and
- volunteering to participate in the study
Key exclusion criteria (5 listed)
- having a risky pregnancy,
- being prohibited from physical activity by a physician,
- having any limb deficiency,
- neurological disease,
- mental deficiency
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Body Awareness
Time frame: Baseline
The Body Awareness Questionnaire will be used to assess body awareness. The questionnaire consists of 18 questions. Participants will be asked to rate each statement on a scale ranging from 1 (1: Not true at all) to 7 (7: Completely true) and the total score will be obtained by summing the scores given for each statement. The total score takes a value between 18 and 126. The higher the total score, the better the body awareness
4 secondary outcomes
Physical Activity Levels
Time frame: Baseline
Age
Time frame: Baseline
Number of births
Time frame: Baseline
weeks of gestation
Time frame: Baselin
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2024.
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Awareness (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2024.